14-day Premium Trial Subscription Try For FreeTry Free
£24.25
-1.00 (-3.96%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days £10.03 £37.80 Friday, 3rd May 2024 SAR.L stock ended at £24.25. This is 3.96% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.74% from a day low at £24.04 to a day high of £25.90.
90 days £10.00 £46.00
52 weeks £10.00 £149.00

Historical Sareum Holdings Plc prices

Date Open High Low Close Volume
Mar 16, 2016 £0.595 £0.595 £0.525 £0.530 36 827 708
Mar 15, 2016 £0.610 £0.610 £0.575 £0.595 55 303 806
Mar 14, 2016 £0.590 £0.660 £0.565 £0.610 103 253 635
Mar 11, 2016 £0.600 £0.690 £0.585 £0.590 153 387 596
Mar 10, 2016 £0.540 £0.795 £0.540 £0.565 293 643 833
Mar 09, 2016 £0.480 £0.560 £0.480 £0.540 111 121 589
Mar 08, 2016 £0.360 £0.515 £0.360 £0.480 110 711 663
Mar 07, 2016 £0.335 £0.370 £0.335 £0.360 36 727 448
Mar 04, 2016 £0.305 £0.335 £0.300 £0.335 33 327 266
Mar 03, 2016 £0.305 £0.305 £0.305 £0.305 4 795 792
Mar 02, 2016 £0.305 £0.305 £0.305 £0.305 3 411 471
Mar 01, 2016 £0.300 £0.305 £0.300 £0.305 6 648 254
Feb 29, 2016 £0.310 £0.310 £0.300 £0.300 9 935 359
Feb 26, 2016 £0.315 £0.315 £0.280 £0.310 30 217 936
Feb 25, 2016 £0.335 £0.340 £0.315 £0.315 35 584 130
Feb 24, 2016 £0.310 £0.320 £0.290 £0.315 37 207 072
Feb 23, 2016 £0.290 £0.320 £0.290 £0.310 26 403 941
Feb 22, 2016 £0.270 £0.315 £0.270 £0.290 34 471 296
Feb 19, 2016 £0.240 £0.270 £0.240 £0.270 11 649 178
Feb 18, 2016 £0.240 £0.240 £0.240 £0.240 9 359 546
Feb 17, 2016 £0.240 £0.240 £0.240 £0.240 1 327 487
Feb 16, 2016 £0.260 £0.260 £0.240 £0.240 11 154 248
Feb 15, 2016 £0.265 £0.265 £0.255 £0.255 11 085 667
Feb 12, 2016 £0.275 £0.275 £0.260 £0.265 11 478 126
Feb 11, 2016 £0.295 £0.295 £0.260 £0.275 27 592 065
Click to get the best stock tips daily for free!

About Sareum Holdings Plc

Sareum Holdings Plc Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering... SAR.L Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT